Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms
Reductions seen in median Gastrointestinal Symptom Rating Scale-Irritable Bowel Syndrome score, Patient Assessment of Gastrointestinal Symptom Severity Index
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
Reduction seen in risk for readmission, wound dehiscence, and hematoma, but no significant differences seen in rates of infection, bleeding
Higher Radon Exposure Linked to Increased Odds of Gestational Diabetes
Nulliparous, pregnant ever-smokers living in counties with higher radon and those living in counties with higher radon and PM2.5 levels have higher odds of GDM
Oral Glucose-Lowering Agents Potential Alternatives to Insulin for Gestational Diabetes
Treatment of gestational diabetes with metformin, and glyburide if needed, does not meet noninferiority criteria versus insulin
Study Quantifies Global T2DM, CVD Burdens Attributable to Sugary Drinks
In 2020, 9.8 percent of all incident type 2 diabetes cases and 3.1 percent of cardiovascular disease cases were attributable to sugar-sweetened beverages
Participation in National Diabetes Prevention Program Is Cost-Saving
Medical costs reduced over two years for privately insured adults with prediabetes participating in the program
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022
Findings seen among privately insured adolescents who identify as transgender and gender-diverse
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation
Proteins Associated With Social Isolation, Loneliness Identified
More than half of the proteins were prospectively linked to cardiovascular disease, type 2 diabetes, stroke, and mortality
Late Eating Tied to Poor Glucose Tolerance
Glucose tolerance worse for people consuming ≥45 percent daily calories after 5 p.m.
